BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,285,363 | +44.6% | 1,451,853 | -5.7% | 0.01% | +60.0% |
| Q2 2023 | $26,473,570 | +44.2% | 1,539,161 | +39.0% | 0.01% | +25.0% |
| Q1 2023 | $18,360,824 | +1266.6% | 1,107,408 | +528.1% | 0.00% | – |
| Q4 2022 | $1,343,536 | -57.4% | 176,317 | -44.4% | 0.00% | -100.0% |
| Q3 2022 | $3,154,000 | -25.6% | 317,243 | -32.0% | 0.00% | 0.0% |
| Q2 2022 | $4,238,000 | -4.2% | 466,793 | +7.1% | 0.00% | – |
| Q1 2022 | $4,424,000 | -92.8% | 435,797 | -88.2% | 0.00% | -100.0% |
| Q4 2021 | $61,504,000 | +568.8% | 3,687,462 | +1779.3% | 0.00% | +100.0% |
| Q3 2021 | $9,196,000 | -11.2% | 196,213 | +15.5% | 0.00% | -50.0% |
| Q2 2021 | $10,354,000 | -15.6% | 169,856 | -14.7% | 0.00% | 0.0% |
| Q1 2021 | $12,269,000 | -25.4% | 199,169 | -13.9% | 0.00% | +100.0% |
| Q4 2020 | $16,446,000 | +665.3% | 231,298 | +303.6% | 0.00% | – |
| Q3 2020 | $2,149,000 | -81.3% | 57,304 | -83.7% | 0.00% | -100.0% |
| Q2 2020 | $11,485,000 | +29.0% | 352,175 | +14.7% | 0.00% | -33.3% |
| Q1 2020 | $8,906,000 | +4023.1% | 307,105 | +2947.3% | 0.00% | – |
| Q3 2019 | $216,000 | – | 10,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $100,609,513 | 48.41% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $514,990,899 | 15.50% |
| M28 Capital Management LP | 304,700 | $5,051,926 | 5.71% |
| Cormorant Asset Management, LP | 4,557,414 | $75,562 | 4.98% |
| Octagon Capital Advisors LP | 1,338,160 | $22,186,693 | 3.19% |
| Ikarian Capital, LLC | 594,686 | $9,859,894 | 2.24% |
| Affinity Asset Advisors, LLC | 389,800 | $6,462,884 | 2.13% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $441,376,031 | 2.07% |
| Ikarian Capital, LLC | 549,600 | $9,112,368 | 2.07% |
| Affinity Asset Advisors, LLC | 320,000 | $5,305,600 | 1.75% |